Guangzhou Wondfo Biotech (300482.SZ) Earnings Analysis
Guangzhou Wondfo Biotech (300482.SZ) next reports earnings on 2026-08-20. Trailing P/E -47.63.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300482.SZ next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.59B |
300482.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | -0.41 CNY | n/a | n/a | n/a |
| 2025-04-25 | 0.2708 CNY | n/a | n/a | n/a |
| 2025-04-09 | 0.39 CNY | n/a | n/a | n/a |
| 2024-10-24 | 0.1666 CNY | n/a | n/a | n/a |
300482.SZ valuation and analyst view
| Trailing P/E | -47.63 |
|---|---|
| Trailing EPS | -0.3595 CNY |
| Price / book | 1.41 |
| Dividend yield | 1.32% |
| Market cap | 7.81B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Guangzhou Wondfo Biotech (300482.SZ)'s next earnings date?
Guangzhou Wondfo Biotech is next scheduled to report on 2026-08-20 and revenue estimate of 0.59B.
Did 300482.SZ beat earnings last quarter?
Consensus estimate data was not available for 300482.SZ's 2026-04-22 report.
What is 300482.SZ's current P/E ratio and EPS?
300482.SZ trades at a trailing P/E of -47.63 on trailing EPS of -0.3594969245569219 CNY.
What do analysts rate 300482.SZ?
300482.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.